arrow_back Back Filing freshness 10-Q FY 2025 SEC EDGAR

download Export Data

SUPERNUS PHARMACEUTICALS, INC.

SUPN

$46.79 ▼ -0.18 (-0.38%) at close

16 Visible periods

32 Metrics

Peer-ranked Benchmarks

Price Chart

Health

Poor

Bearish

auto_awesome

Analytical Summary

SUPERNUS PHARMACEUTICALS, INC. faces fundamental challenges with weakness in Profit Margin (%) and Operating Margin (%). The fundamentals warrant careful consideration of downside risks.

Market Cap $2.6B

Dividend Yield —

Revenue Growth 18.3% ↗

Op. Margin -8.7% ↘

ROIC -4.6% ↘

FCF / Share $0.81 ↘

Trailing P/E —

Price / Book 2.5x

FCF Yield 1.7%

Debt / Equity —

info Valuation on last close. End-of-day price, Aug 6, 2026.

16-Year Financial Trajectory

Annual

Metric Value Trend Year over Year Percentile

Revenue Total top-line sales

$718.95M

↑ +18.3% —

Net Income Profit after all expenses

$-38.55M

↓ -3029.3% —

Operating Margin Operating profit as % of sales

-8.7%

↓ -898.9% 17th

FCF / Share Free cash flow per share

$0.81

↓ -59.8% —

trending_up

Bullish Indicators

No bullish signals detected.

warning

Bearish Risks

Operating Margin (%)Operating Margin (%) is in the bottom quartile
Profit Margin (%)Profit Margin (%) is in the bottom quartile

Health Breakdown

Profitability ↓

Returns

Cash Quality

Financial view

Statement lens

Choose the reporting cadence, isolate a period range, or search directly for a metric.

Cadence

Annual Quarterly

Range

→

📈 Is growth accelerating? 7 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Revenue Growth YoY (%)	18.3% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+129%)	-8.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-212%)	15.1% Good ↑ Good Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+89%)	11.4% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+43%)	32.5% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+306%)	-3.9% Weak ↓ Weak Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Below avg (-149%)	35.3% Excellent → Excellent Stable Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+341%)	40.6% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+407%)	48.9% Excellent ↓ Excellent Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+511%)	18.3% Good ↓ Good Declining Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+129%)	915.4% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+11343%)	712.1% Excellent ↑ Excellent Improving Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8801%)	84.3% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+954%)	657.5% Excellent Excellent Year-over-year change in total revenue Optimal: > 10% vs Sector: Above avg (+8119%)	—	—
EPS Growth YoY (%)	N/M	-98.2% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	11.9% Fair ↑ Fair Improving Year-over-year change in earnings per share Optimal: > 10%	-58.1% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	11.6% Fair ↓ Fair Declining Year-over-year change in earnings per share Optimal: > 10%	1.4% Caution ↓ Caution Declining Year-over-year change in earnings per share Optimal: > 10%	88.5% Excellent ↓ Excellent Declining Year-over-year change in earnings per share Optimal: > 10%	-38.6% Weak ↓ Weak Declining Year-over-year change in earnings per share Optimal: > 10%	513.3% Excellent Excellent Year-over-year change in earnings per share Optimal: > 10%	-36.2% Weak Weak Year-over-year change in earnings per share Optimal: > 10%	N/M	—	—	—	—	—
Net Income Growth YoY (%)	N/M	-97.8% Weak ↓ Weak Declining Year-over-year change in net income	13.6% Fair ↑ Fair Improving Year-over-year change in net income	-57.9% Weak ↓ Weak Declining Year-over-year change in net income	12.3% Fair ↓ Fair Declining Year-over-year change in net income	1.9% Caution ↓ Caution Declining Year-over-year change in net income	93.8% Excellent ↓ Excellent Declining Year-over-year change in net income	-37.2% Weak ↓ Weak Declining Year-over-year change in net income	550.8% Excellent ↑ Excellent Improving Year-over-year change in net income	-29.5% Weak Weak Year-over-year change in net income	N/M	-99.4% Weak Weak Year-over-year change in net income	N/M	N/M	—	—
FCF Growth YoY (%)	-59.8% Weak ↓ Weak Declining Year-over-year change in free cash flow	-6.9% Weak → Weak Stable Year-over-year change in free cash flow	-9.1% Weak ↓ Weak Declining Year-over-year change in free cash flow	-6.7% Weak ↓ Weak Declining Year-over-year change in free cash flow	-4.2% Weak ↓ Weak Declining Year-over-year change in free cash flow	8.7% Fair ↓ Fair Declining Year-over-year change in free cash flow	11.1% Fair ↓ Fair Declining Year-over-year change in free cash flow	68.3% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	108.5% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	274.2% Excellent ↑ Excellent Improving Year-over-year change in free cash flow	N/M	31.9% Excellent ↓ Excellent Declining Year-over-year change in free cash flow	88.0% Excellent Excellent Year-over-year change in free cash flow	-11.1% Weak Weak Year-over-year change in free cash flow	—	—
Revenue CAGR 3Y (%)	7.4% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	5.3% Fair ↓ Fair Declining Compound annual revenue growth over 3 years	19.3% Excellent ↑ Excellent Improving Compound annual revenue growth over 3 years	12.3% Good ↓ Good Declining Compound annual revenue growth over 3 years	19.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	22.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	41.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	35.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	161.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	360.4% Excellent ↓ Excellent Declining Compound annual revenue growth over 3 years	433.7% Excellent Excellent Compound annual revenue growth over 3 years	384.0% Excellent Excellent Compound annual revenue growth over 3 years	—	—	—	—
Revenue CAGR 5Y (%)	12.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	8.2% Good ↓ Good Declining Compound annual revenue growth over 5 years	17.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	21.9% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	29.2% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	26.3% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	102.5% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	189.7% Excellent ↓ Excellent Declining Compound annual revenue growth over 5 years	205.9% Excellent Excellent Compound annual revenue growth over 5 years	323.5% Excellent Excellent Compound annual revenue growth over 5 years	—	—	—	—	—	—
EPS CAGR 3Y (%)	—	-79.8% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-19.4% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	-22.0% Weak ↓ Weak Declining Compound annual EPS growth over 3 years	28.7% Excellent ↓ Excellent Declining Compound annual EPS growth over 3 years	5.5% Fair ↓ Fair Declining Compound annual EPS growth over 3 years	92.2% Excellent Excellent Compound annual EPS growth over 3 years	34.0% Excellent Excellent Compound annual EPS growth over 3 years	—	—	—	—	—	—	—	—

💰 Are margins durable? 5 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Operating Margin (%) (%)	-8.7% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-158%)	-0.9% Weak ↓ Weak Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-106%)	6.9% Caution ↓ Caution Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-54%)	14.8% Fair ↓ Fair Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: At sector avg	33.4% Excellent ↓ Excellent Declining Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+123%)	37.8% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+152%)	35.3% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+136%)	32.9% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+120%)	25.2% Excellent ↑ Excellent Improving Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+68%)	12.2% Fair Fair Operating income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-18%)	19.9% Good Good Operating income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+32%)	—	—	—	—	—
Effective Tax Rate (%) (%)	21.4% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	52.5% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	0.1% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	27.0% Caution ↑ Caution Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	24.7% Fair ↓ Fair Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	23.3% Fair ↑ Fair Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	20.8% Good ↑ Good Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	43.1% Weak ↑ Weak Improving Actual taxes paid relative to pre-tax income Optimal: 15-25%	-81.1% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	6.4% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—	—	0.0% Excellent ↓ Excellent Declining Actual taxes paid relative to pre-tax income Optimal: 15-25%	41.2% Weak Weak Actual taxes paid relative to pre-tax income Optimal: 15-25%	1.0% Excellent Excellent Actual taxes paid relative to pre-tax income Optimal: 15-25%	—
Profit Margin (%) (%)	-5.4% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-145%)	0.2% Weak ↓ Weak Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-98%)	9.1% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-24%)	9.2% Caution ↓ Caution Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-23%)	24.4% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+103%)	28.8% Excellent → Excellent Stable Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+140%)	27.1% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+126%)	19.0% Good ↓ Good Declining Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+58%)	42.4% Excellent ↑ Excellent Improving Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+254%)	9.7% Caution Caution Net income as a percentage of revenue Optimal: > 15% vs Sector: Below avg (-19%)	16.3% Good Good Net income as a percentage of revenue Optimal: > 15% vs Sector: Above avg (+36%)	—	—	—	—	—
FCF Margin (%) (%)	6.4% Caution ↓ Caution Declining Free cash flow as a percentage of revenue Optimal: > 10%	18.2% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	17.5% Good ↓ Good Declining Free cash flow as a percentage of revenue Optimal: > 10%	21.9% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	25.9% Excellent ↓ Excellent Declining Free cash flow as a percentage of revenue Optimal: > 10%	35.7% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	31.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	37.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	30.3% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	20.8% Excellent ↑ Excellent Improving Free cash flow as a percentage of revenue Optimal: > 10%	5.9% Caution Caution Free cash flow as a percentage of revenue Optimal: > 10%	-495.8% Weak Weak Free cash flow as a percentage of revenue Optimal: > 10%	—	—	—	—
FCF / Net Income (x)	-1.19x Weak ↓ Weak Declining Free cash flow relative to reported net income Optimal: > 1x	83.99x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.92x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	2.38x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	1.06x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.24x Good → Good Stable Free cash flow relative to reported net income Optimal: > 1x	1.15x Fair ↓ Fair Declining Free cash flow relative to reported net income Optimal: > 1x	1.97x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.71x Caution ↓ Caution Declining Free cash flow relative to reported net income Optimal: > 1x	2.14x Excellent ↑ Excellent Improving Free cash flow relative to reported net income Optimal: > 1x	0.36x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	0.65x Weak ↑ Weak Improving Free cash flow relative to reported net income Optimal: > 1x	1.04x Fair ↑ Fair Improving Free cash flow relative to reported net income Optimal: > 1x	-0.69x Weak Weak Free cash flow relative to reported net income Optimal: > 1x	0.85x Caution Caution Free cash flow relative to reported net income Optimal: > 1x	—

🎯 Is capital allocation efficient? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Return on Invested Capital (%)	-4.6% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-0.3% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	5.2% Caution ↓ Caution Declining Return earned on debt + equity capital invested Optimal: > 10%	7.7% Fair ↓ Fair Declining Return earned on debt + equity capital invested Optimal: > 10%	17.6% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	19.1% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	25.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	21.2% Excellent ↓ Excellent Declining Return earned on debt + equity capital invested Optimal: > 10%	51.2% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	13.9% Good ↑ Good Improving Return earned on debt + equity capital invested Optimal: > 10%	26.8% Excellent ↑ Excellent Improving Return earned on debt + equity capital invested Optimal: > 10%	-146.2% Weak ↓ Weak Declining Return earned on debt + equity capital invested Optimal: > 10%	-52.2% Weak ↑ Weak Improving Return earned on debt + equity capital invested Optimal: > 10%	-235.2% Weak Weak Return earned on debt + equity capital invested Optimal: > 10%	89.6% Excellent Excellent Return earned on debt + equity capital invested Optimal: > 10%	—
Return on Capital (%) (%)	-4.3% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	-0.4% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	2.7% Weak ↓ Weak Declining Operating profit relative to total assets Optimal: > 10%	5.1% Caution ↓ Caution Declining Operating profit relative to total assets Optimal: > 10%	11.5% Good ↓ Good Declining Operating profit relative to total assets Optimal: > 10%	12.8% Good ↓ Good Declining Operating profit relative to total assets Optimal: > 10%	14.8% Good ↓ Good Declining Operating profit relative to total assets Optimal: > 10%	23.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	17.5% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	9.4% Fair ↑ Fair Improving Operating profit relative to total assets Optimal: > 10%	17.6% Excellent ↑ Excellent Improving Operating profit relative to total assets Optimal: > 10%	-55.8% Weak → Weak Stable Operating profit relative to total assets Optimal: > 10%	-44.9% Weak Weak Operating profit relative to total assets Optimal: > 10%	-70.3% Weak Weak Operating profit relative to total assets Optimal: > 10%	—	—
Return on Common Equity (%) (%)	-3.6% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-124%)	0.1% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-99%)	6.9% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-54%)	6.5% Caution ↓ Caution Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-56%)	17.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+14%)	19.0% Good ↓ Good Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+27%)	24.5% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+63%)	21.4% Excellent ↓ Excellent Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+43%)	47.6% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+217%)	11.8% Fair ↑ Fair Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-21%)	27.8% Excellent ↑ Excellent Improving Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+86%)	-275.7% Weak ↓ Weak Declining Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-1938%)	-80.4% Weak Weak Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Below avg (-636%)	—	86.8% Excellent Excellent Profit generated per dollar of shareholder equity Optimal: > 15% vs Sector: Above avg (+479%)	—

⚖️ Is the balance sheet risky? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Debt to Equity (x)	—	—	—	—	—	—	—	—	—	—	—	—	0.40x Good Good Total debt relative to shareholder equity Optimal: < 0.6x vs Sector: Below avg (-33%)	—	—	—
Interest Coverage (x)	—	-3.99x Weak ↓ Weak Declining Operating income divided by interest expense Optimal: > 5x	9.91x Good ↑ Good Improving Operating income divided by interest expense Optimal: > 5x	4.37x Fair ↓ Fair Declining Operating income divided by interest expense Optimal: > 5x	8.94x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	8.16x Good ↓ Good Declining Operating income divided by interest expense Optimal: > 5x	10.44x Excellent ↓ Excellent Declining Operating income divided by interest expense Optimal: > 5x	742.84x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	99.85x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	14.37x Excellent ↑ Excellent Improving Operating income divided by interest expense Optimal: > 5x	4.88x Fair ↑ Fair Improving Operating income divided by interest expense Optimal: > 5x	-7.89x Weak ↑ Weak Improving Operating income divided by interest expense Optimal: > 5x	-11.80x Weak Weak Operating income divided by interest expense Optimal: > 5x	-20.23x Weak Weak Operating income divided by interest expense Optimal: > 5x	—	—
Net Debt (USD)	$-128.45M	$-75.05M	$-93.12M	$-203.43M	$-288.64M	$-181.38M	$-192.25M	$-100.30M	$-66.40M	$-34.15M	$-36.40M	$-32.98M	$-17.08M	$-48.54M	$-23.74M	$-31.41M
Debt / EBITDA (x)	—	—	—	—	—	—	—	—	—	—	—	—	-0.56x Excellent Excellent Debt relative to earnings before interest, taxes, depreciation Optimal: < 2x	—	—	—

📊 What does each share earn? 6 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Revenue per Share (USD)	$12.74	$11.14	$12.43	$10.92	$9.89	$7.49	$7.86	$5.95	$4.35	$3.04	$2.89	$0.38	$0.08	$0.50	$0.07	—
Basic EPS, GAAP (USD)	$-0.68	$0.02	$1.13	$1.01	$2.41	$2.16	$2.13	$1.13	$1.84	$0.30	$0.47	$-2.90	—	—	—	—
Free Cash Flow per Share (USD)	$0.81	$2.03	$2.18	$2.39	$2.56	$2.68	$2.46	$2.22	$1.32	$0.63	$0.17	$-1.87	$-2.75	$-22.97	$-20.68	—
Book Value per Share (USD)	$18.48	$16.53	$16.64	$15.32	$14.18	$11.33	$8.66	$5.21	$3.84	$2.43	$1.66	$0.84	$1.88	$5.68	$-27.91	—
Tangible Book Value per Share (USD)	$6.39	$5.07	$1.25	$-1.62	$5.76	$10.86	$8.06	$4.51	$3.11	$2.41	$1.66	$0.81	$1.86	$5.13	$-27.91	—
Basic Weighted Avg Shares (shares)	56.45M	54.54M	53.67M	53.10M	52.62M	52.41M	51.99M	50.76M	49.47M	47.49M	42.26M	31.85M	17.44M	1.61M	1.59M	—

🏦 How resilient is the balance sheet? 3 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Working Capital (USD)	$306.01M	$393.67M	$46.19M	$286.21M	$385.31M	$312.06M	$332.13M	$105.45M	$70.66M	$49.88M	$81.40M	$70.76M	$68.76M	$30.63M	—	—
LT Debt (USD)	—	—	—	—	—	—	—	—	—	—	—	—	$23.23M	—	—	—
Total Equity (USD)	$1.06B	$921.52M	$886.20M	$815.85M	$744.86M	$595.43M	$453.02M	$267.48M	$191.75M	$118.88M	$71.35M	$33.46M	$57.57M	$9.44M	$-44.32M	$-6.16M

📋 What is driving earnings? 4 metrics

Metric	FY 2025 Dec 31, 2025 10-K ↗	FY 2024 Dec 31, 2024 10-K ↗	FY 2023 Dec 31, 2022 10-K ↗	FY 2022 Dec 31, 2021 10-K ↗	FY 2021 Dec 31, 2020 10-K ↗	FY 2020 Dec 31, 2019 10-K ↗	FY 2019 Dec 31, 2018 10-K ↗	FY 2018 Dec 31, 2017 10-K ↗	FY 2017 Dec 31, 2016 10-K ↗	FY 2016 Dec 31, 2015 10-K ↗	FY 2015 Dec 31, 2014 10-K ↗	FY 2014 Dec 31, 2013 10-K ↗	FY 2013 Dec 31, 2012 10-K ↗	FY 2012 Dec 31, 2011 10-K ↗	FY 2011 Dec 31, 2010 10-K ↗	FY 2010 Dec 31, 2009 10-K ↗
Sales/Revenue/Turnover (USD)	$718.95M	$607.52M	$667.24M	$579.77M	$520.40M	$392.75M	$408.90M	$302.24M	$215.00M	$144.43M	$122.05M	$12.02M	$1.48M	$803.00K	$106.00K	—
Depreciation Expense (USD)	$91.56M	$84.86M	$85.54M	$32.59M	$18.14M	$6.66M	$7.06M	$8.13M	$2.40M	$921.00K	$928.00K	$742.00K	$871.00K	$879.00K	$1.19M	—
Net Income, GAAP (USD)	$-38.55M	$1.32M	$60.71M	$53.42M	$126.95M	$113.06M	$110.99M	$57.28M	$91.22M	$14.02M	$19.87M	$-92.27M	$-46.28M	$53.81M	$-38.46M	—
Operating Cash Flow (USD)	$47.33M	$111.08M	$116.83M	$127.13M	$138.40M	$143.13M	$128.99M	$114.64M	$66.81M	$32.12M	$7.73M	$-57.95M	$-47.20M	$-36.19M	$-32.54M	—

⌨️ Keyboard Shortcuts

/ Search

Esc Clear

A Annual

Q Quarterly

1-7 Jump to category

R Reset

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 16 years · 60 quarters

SUPERNUS PHARMACEUTICALS, INC.

Analytical Summary

16-Year Financial Trajectory

Bullish Indicators

Bearish Risks

Health Breakdown

Statement lens

Benchmark Lens

Signals

Percentile Rankings

Peer Comparison

Compare SUPN with peers